These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
6. Presence of a hypovascular hepatic nodule showing hypointensity on hepatocyte-phase image is a risk factor for hypervascular hepatocellular carcinoma. Ichikawa S; Ichikawa T; Motosugi U; Sano K; Morisaka H; Enomoto N; Matsuda M; Fujii H; Araki T J Magn Reson Imaging; 2014 Feb; 39(2):293-7. PubMed ID: 23633285 [TBL] [Abstract][Full Text] [Related]
7. Gadoxetic acid-enhanced hepatobiliary phase MRI and high-b-value diffusion-weighted imaging to distinguish well-differentiated hepatocellular carcinomas from benign nodules in patients with chronic liver disease. Lee MH; Kim SH; Park MJ; Park CK; Rhim H AJR Am J Roentgenol; 2011 Nov; 197(5):W868-75. PubMed ID: 22021534 [TBL] [Abstract][Full Text] [Related]
8. Differentiation Between Hepatocellular Carcinoma Showing Hyperintensity on the Hepatobiliary Phase of Gadoxetic Acid-Enhanced MRI and Focal Nodular Hyperplasia by CT and MRI. Kitao A; Matsui O; Yoneda N; Kita R; Kozaka K; Kobayashi S; Gabata T AJR Am J Roentgenol; 2018 Aug; 211(2):347-357. PubMed ID: 29708786 [TBL] [Abstract][Full Text] [Related]
9. Hepatocellular carcinoma: clinical significance of signal heterogeneity in the hepatobiliary phase of gadoxetic acid-enhanced MR imaging. Fujita N; Nishie A; Kubo Y; Asayama Y; Ushijima Y; Takayama Y; Moirta K; Shirabe K; Aishima S; Honda H Eur Radiol; 2015 Jan; 25(1):211-20. PubMed ID: 25063395 [TBL] [Abstract][Full Text] [Related]
11. Non-hypervascular Hypointense Nodules on Hepatocyte Phase Gadoxetic Acid-Enhanced MR Images: Transformation of MR Hepatobiliary Hypointense Nodules into Hypervascular Hepatocellular Carcinomas. Cho YK; Kim JW; Kim MY; Cho HJ Gut Liver; 2018 Jan; 12(1):79-85. PubMed ID: 28798287 [TBL] [Abstract][Full Text] [Related]
12. Imaging features of subcentimeter hypointense nodules on gadoxetic acid-enhanced hepatobiliary phase MR imaging that progress to hypervascular hepatocellular carcinoma in patients with chronic liver disease. Jang KM; Kim SH; Kim YK; Choi D Acta Radiol; 2015 May; 56(5):526-35. PubMed ID: 24838304 [TBL] [Abstract][Full Text] [Related]
13. Distinguishing hypervascular pseudolesions of the liver from hypervascular hepatocellular carcinomas with gadoxetic acid-enhanced MR imaging. Motosugi U; Ichikawa T; Sou H; Sano K; Tominaga L; Muhi A; Araki T Radiology; 2010 Jul; 256(1):151-8. PubMed ID: 20574092 [TBL] [Abstract][Full Text] [Related]
14. Intrahepatic distant recurrence after radiofrequency ablation for hepatocellular carcinoma: precursor nodules on pre-procedural gadoxetic acid-enhanced liver magnetic resonance imaging. Song KD; Rhim H; Lee MW; Kim YS; Kang TW Acta Radiol; 2017 Jul; 58(7):778-785. PubMed ID: 27903759 [TBL] [Abstract][Full Text] [Related]
15. Hyperintense HCC on hepatobiliary phase images of gadoxetic acid-enhanced MRI: correlation with clinical and pathological features. Kim JY; Kim MJ; Kim KA; Jeong HT; Park YN Eur J Radiol; 2012 Dec; 81(12):3877-82. PubMed ID: 22954410 [TBL] [Abstract][Full Text] [Related]
16. Gadoxetic acid-enhanced magnetic resonance imaging can predict the pathologic stage of solitary hepatocellular carcinoma. Chou YC; Lao IH; Hsieh PL; Su YY; Mak CW; Sun DP; Sheu MJ; Kuo HT; Chen TJ; Ho CH; Kuo YT World J Gastroenterol; 2019 Jun; 25(21):2636-2649. PubMed ID: 31210715 [TBL] [Abstract][Full Text] [Related]
17. Hepatocellular carcinoma: hepatocyte-selective enhancement at gadoxetic acid-enhanced MR imaging--correlation with expression of sinusoidal and canalicular transporters and bile accumulation. Tsuboyama T; Onishi H; Kim T; Akita H; Hori M; Tatsumi M; Nakamoto A; Nagano H; Matsuura N; Wakasa K; Tomoda K Radiology; 2010 Jun; 255(3):824-33. PubMed ID: 20501720 [TBL] [Abstract][Full Text] [Related]
18. Non-hypervascular hepatobiliary phase hypointense nodules on gadoxetic acid-enhanced MRI: risk of HCC recurrence after radiofrequency ablation. Lee DH; Lee JM; Lee JY; Kim SH; Kim JH; Yoon JH; Kim YJ; Lee JH; Yu SJ; Han JK; Choi BI J Hepatol; 2015 May; 62(5):1122-30. PubMed ID: 25529623 [TBL] [Abstract][Full Text] [Related]
19. Non-Hypervascular Hypointense Hepatic Nodules during the Hepatobiliary Phase of Gadolinium-Ethoxybenzyl-Diethylenetriamine Pentaacetic Acid-Enhanced MRI as a Risk Factor of Intrahepatic Distant Recurrence after Radiofrequency Ablation of Hepatocellular Carcinoma. Iwamoto T; Imai Y; Igura T; Kogita S; Sawai Y; Fukuda K; Yamaguchi Y; Matsumoto Y; Nakahara M; Morimoto O; Ohashi H; Fujita N; Kudo M; Takehara T Dig Dis; 2017; 35(6):574-582. PubMed ID: 29040990 [TBL] [Abstract][Full Text] [Related]
20. Hepatocyte transporter expression in FNH and FNH-like nodule: correlation with signal intensity on gadoxetic acid enhanced magnetic resonance images. Yoneda N; Matsui O; Kitao A; Kita R; Kozaka K; Koda W; Kobayashi S; Gabata T; Ikeda H; Sato Y; Nakanuma Y Jpn J Radiol; 2012 Jul; 30(6):499-508. PubMed ID: 22618456 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]